Federated Hermes Inc. Buys 871 Shares of Amedisys, Inc. (NASDAQ:AMED)

Federated Hermes Inc. grew its stake in Amedisys, Inc. (NASDAQ:AMED) by 32.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,518 shares of the health services provider’s stock after purchasing an additional 871 shares during the period. Federated Hermes Inc.’s holdings in Amedisys were worth $334,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Pentwater Capital Management LP raised its holdings in Amedisys by 239.5% during the 3rd quarter. Pentwater Capital Management LP now owns 1,144,000 shares of the health services provider’s stock valued at $106,850,000 after buying an additional 807,000 shares during the period. Westchester Capital Management LLC grew its holdings in Amedisys by 269.7% during the 3rd quarter. Westchester Capital Management LLC now owns 850,386 shares of the health services provider’s stock valued at $79,426,000 after purchasing an additional 620,386 shares during the last quarter. Alpine Associates Management Inc. raised its position in Amedisys by 46.6% in the 3rd quarter. Alpine Associates Management Inc. now owns 1,033,497 shares of the health services provider’s stock worth $96,529,000 after purchasing an additional 328,300 shares during the period. Bank of Nova Scotia bought a new stake in Amedisys in the third quarter worth about $26,671,000. Finally, AQR Arbitrage LLC boosted its position in shares of Amedisys by 407.7% during the third quarter. AQR Arbitrage LLC now owns 314,321 shares of the health services provider’s stock valued at $29,358,000 after buying an additional 252,405 shares during the period. 94.36% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Royal Bank of Canada increased their price target on Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a report on Monday, March 25th. Cantor Fitzgerald reiterated a “neutral” rating and set a $101.00 target price on shares of Amedisys in a research report on Thursday, April 25th. StockNews.com upgraded shares of Amedisys from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Seven investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Amedisys presently has a consensus rating of “Hold” and an average price target of $97.50.

Amedisys Stock Performance

Shares of Amedisys stock opened at $92.08 on Friday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.31. The stock’s fifty day moving average price is $92.36 and its 200-day moving average price is $93.32. The firm has a market cap of $3.01 billion, a P/E ratio of -143.87, a P/E/G ratio of 3.44 and a beta of 0.84. Amedisys, Inc. has a 12 month low of $73.10 and a 12 month high of $96.44.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, beating the consensus estimate of $1.02 by $0.01. Amedisys had a negative net margin of 0.91% and a positive return on equity of 12.85%. The business had revenue of $571.41 million during the quarter, compared to analyst estimates of $565.38 million. During the same quarter in the previous year, the business posted $1.00 EPS. The company’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, equities research analysts expect that Amedisys, Inc. will post 4.57 earnings per share for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.